Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,538 | -90,355 | -58,141 | 109,195 | 136,283 |
| Depreciation Amortization | 233 | 153 | 72 | 93 | 34 |
| Accounts payable and accrued liabilities | -1,709 | -169 | -630 | -509 | -1,654 |
| Other Working Capital | -3,649 | -3,468 | 1,180 | 11,176 | 16,187 |
| Other Operating Activity | 18,519 | 11,836 | 6,522 | -246,619 | -252,531 |
| Operating Cash Flow | $-116,144 | $-82,003 | $-50,997 | $-126,664 | $-101,681 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -208 | -208 | -159 | -1,042 | -251 |
| Net Acquisitions | N/A | N/A | N/A | 275,000 | 275,000 |
| Purchase Of Investment | -307,371 | -170,592 | -89,139 | -377,916 | -217,497 |
| Sale Of Investment | 291,915 | 198,094 | 104,482 | 352,933 | 220,333 |
| Investing Cash Flow | $-15,664 | $27,294 | $15,184 | $248,975 | $277,585 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,825 | 1,825 | 1,825 | 2,375 | 2,200 |
| Common Stock Issued | 38,678 | 38,566 | -36 | 6,020 | 5,826 |
| Other Financing Activity | 0 | 0 | 0 | -34,328 | -1,047 |
| Financing Cash Flow | $40,503 | $40,391 | $1,789 | $-25,933 | $6,979 |
| Beginning Cash Position | 156,152 | 156,152 | 156,152 | 59,774 | 59,774 |
| End Cash Position | 64,847 | 141,834 | 122,128 | 156,152 | 242,657 |
| Net Cash Flow | $-91,305 | $-14,318 | $-34,024 | $96,378 | $182,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -116,144 | -82,003 | -50,997 | -126,664 | -101,681 |
| Capital Expenditure | -208 | -208 | -159 | -1,133 | -251 |
| Free Cash Flow | -116,352 | -82,211 | -51,156 | -127,797 | -101,932 |